Foghorn Therapeutics Stock (NASDAQ:FHTX), Quotes and News Summary

Q: What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Foghorn Therapeutics Stock (NASDAQ: FHTX) stock price, news, charts, stock research, profile.

Open	$5.480
Close	$5.300
Volume / Avg.	118.158K / 164.312K
Day Range	5.140 - 5.940
52 Wk Range	2.700 - 9.970
Market Cap	$225.599M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	4.12%
Days to Cover	16.99

Recent News

Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher

Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.

Henry Khederian

Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.

Lisa Levin

Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday

Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Foghorn Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines tar...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Foghorn Therapeutics (FHTX) stock?

You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.

View our list of the best stock brokerages.

Who are Foghorn Therapeutics's (FHTX) competitors?

Other companies in Foghorn Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Abeona Therapeutics (NASDAQ:ABEO).

What is the target price for Foghorn Therapeutics (FHTX) stock?

The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Wedbush on Wednesday, April 10, 2024. The analyst firm set a price target for 13.00 expecting FHTX to rise to within 12 months (a possible 145.28% upside). 13 analyst firms have reported ratings in the last year.

Current Stock Price for Foghorn Therapeutics (FHTX)?

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $5.3 last updated April 19, 2024 at 4:00 PM EDT.

Does Foghorn Therapeutics (FHTX) pay a dividend?

There are no upcoming dividends for Foghorn Therapeutics.

When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?

Foghorn Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is Foghorn Therapeutics (FHTX) going to split?

There is no upcoming split for Foghorn Therapeutics.

What sector and industry does Foghorn Therapeutics (FHTX) operate in?

Foghorn Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-